Search / Trial NCT00000386

Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)

Launched by NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH) · Nov 2, 1999

Trial Information

Current as of October 18, 2024

Completed

Keywords

Adolescence Child Comparative Study Family Female Human Male Obsessive Compulsive Disorder Relaxation Techniques Obsessive Compulsive Disorder *Therapy

Description

To evaluate a standardized multicomponent cognitive behavioral treatment program for child and adolescent obsessive-compulsive disorder (OCD). The treatment program consists of individual Exposure and Response Prevention (ERP) for the OCD child plus a concurrent family intervention designed to reduce OCD-related family conflict, facilitate family disengagement from the affected child's OCD behavior, and rebuild normal family interaction patterns. The ERP/Family Treatment Program is compared with Relaxation Training (RT). OCD is a chronic, often disabling disorder in childhood that has been...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • -
  • Patients must have:
  • Obsessive-compulsive disorder for which he/she has not received medication.

About National Institute Of Mental Health (Nimh)

The National Institute of Mental Health (NIMH) is a leading federal agency dedicated to advancing the understanding and treatment of mental health disorders through innovative research and clinical trials. As part of the National Institutes of Health (NIH), NIMH focuses on a broad spectrum of mental health issues, including mood disorders, anxiety disorders, schizophrenia, and developmental disorders. By fostering collaboration among researchers, clinicians, and the community, NIMH aims to translate scientific discoveries into effective interventions and improve mental health outcomes for individuals across the lifespan. Through its commitment to rigorous research methodologies and ethical standards, NIMH plays a pivotal role in shaping the future of mental health care and policy.

Locations

Los Angeles, California, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0